Prevalence and isotypic complexity of the anti-Chinese hamster ovary host cell protein antibodies in normal human serum

AAPS Journal

Volumn 12, Issue 1, 2010, Pages 98-106

  Xue, Li ^a   Johnson, Rasheeda ^b   Gorovits, Boris ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

Antibody isotypes; Chinese hamster ovary cells; Host cell protein; Immunogenicity response characterization; Specificity

Indexed keywords

ANTIBODY; HOST CELL PROTEIN ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN G4 ANTIBODY; IMMUNOGLOBULIN M; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CHO CELL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; SERUM; ANIMAL; BLOOD; CRICETULUS; HAMSTER; IMMUNOLOGY;

ANIMALS; ANTIBODY SPECIFICITY; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN M;

EID: 77449104949     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-009-9165-5     Document Type: Article

References (30)

1. T Schirrmann L Al-Halabi S Dubel M Hust 2008 Production systems for recombinant antibodies Front Biosci. 13 4576 94 10.2741/3024 1:CAS:528:DC%2BD1cXnsVOjsLw%3D 18508530 (Pubitemid 351589183)
2. D Jones N Kroos R Anema 2003 High-level expression of recombinant IgG in the human cell line per.c6 Biotechnol Prog. 9 1 163 8 10.1021/bp025574h (Pubitemid 36219317)
3. RG Werner W Noe K Kopp M Schluter 1998 Appropriate mammalian expression systems for biopharmaceuticals Arzneimittelforschung. 48 8 870 80 1:CAS:528:DyaK1cXlsF2js74%3D 9748718
4. FM Wurm 2004 Production of recombinant protein therapeutics in cultivated mammalian cells Nat Biotechnol. 22 11 1393 8 10.1038/nbt1026 1:CAS:528:DC%2BD2cXptlSls7k%3D 15529164 (Pubitemid 39482858)
5. Jayapal KP, Wlaschin KF, Hu W. Recombinant protein therapeutics from CHO cells-20 years and counting. CHO Consortium SBE special section. 2007;40-7.
6. E Koren LA Zuckerman AR Mire-Sluis 2002 Immune responses to therapeutic proteins in humans-clinical significance, assessment and prediction Curr Pharm Biotechnol. 3 4 349 60 10.2174/1389201023378175 1:CAS:528:DC%2BD38XovF2qsb8%3D 12463417 (Pubitemid 35364009)
7. H Schellekens 2005 Factors influencing the immunogenicity of therapeutic proteins Nephrol Dial Transplant. 20 Suppl 6 3 9
8. G Shankar C Pendley KE Stein 2007 A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs Nat Biotechnol. 25 5 555 61 10.1038/nbt1303 1:CAS:528:DC%2BD2sXkvFWns70%3D 17483842 (Pubitemid 46834844)
9. K Hoffman 2000 Strategies for host cell protein analysis BioPharm. 13 38 45 1:CAS:528:DC%2BD3cXktFCls74%3D
10. Van Cleave VH. Validation of immunoassays for anti-drug antibodies. In: Brown F, Mire-Sluis AR, editors. Immunogenicity of therapeutic biological products. Dev Biol. Basel: Karger; 2003;112:107-12.
11. G Shankar V Devanarayan L Amaravadi, et al. 2008 Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products J Pharm Biomed Anal. 48 5 1267 81 10.1016/j.jpba.2008.09. 020 1:CAS:528:DC%2BD1MXntlyisQ%3D%3D 18993008
12. M Wadhwa C Bird P Dilger, et al. 2003 Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals J Immunol Methods. 278 1-2 1 17 10.1016/S0022-1759(03)00206-0 1:CAS:528:DC%2BD3sXmvVOhsb8%3D 12957392 (Pubitemid 37281188)
13. E Koren HW Smith E Shores, et al. 2008 Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products J Immunol Methods. 333 1-2 1 9 10.1016/j.jim.2008.01.001 1:CAS:528:DC%2BD1cXktlWku70%3D 18275969
14. J Thippawong 2006 Inhaled cytokines and cytokine antagonists Adv Drug Deliv Rev. 58 9-10 1089 105 10.1016/j.addr.2006.07.014 (Pubitemid 44709268)
15. RC Aalberse R van der Gagg J van Leeuwen 1983 Serologic aspects of IgG4 antibodies. I. Prolonged immunisation results in an IgG4-restricted response J Immunol. 130 2 722 6 1:STN:280:DyaL3s%2Fotl2ksg%3D%3D 6600252
16. R Urbanek 1988 IgG subclasses and subclass distribution in allergic disorders Monogr Allergy. 23 33 40 1:STN:280:DyaL1c3mtFegtA%3D%3D 3386644
17. AH Lucas 1990 IgG subclass restricted immune responses to allergens Springer Semin Immunopathol. 2 4 385 400
18. GR Siber PH Schur AC Aisenber SA Weitzmann G Schiffman 1980 Correlation between serum IgG2 concentrations and the antibody response to bacterial polysaccharide antigens New Engl J Med. 303 4 178 82 1:STN:280: DyaL3c3gvF2gtQ%3D%3D 6966763
19. LJ Kricka 1999 Human anti-animal antibody interferences in immunological assays Clin Chem. 45 7 942 56 1:CAS:528:DyaK1MXktlOgurc%3D 10388468
20. BR Hawkins GC Saueracker RL Dawkins, et al. 1980 Population study of heterophile antibodies Vox Sang. 39 339 42 10.1111/j.1423-0410.1980.tb02973.x 1:STN:280:DyaL3M3nslamtA%3D%3D 6894990
21. G Schaison P Thomopoulos, et al. 1981 False hyperthyrotropinemia induced by heterophilic antibodies against rabbit serum J Clin Endocrinol Metab. 53 1 200 2 10.1210/jcem-53-1-200 1:STN:280:DyaL3M3hsFyltg%3D%3D 6894601
22. G Padova G Briguglia P Tita, et al. 1991 Hypergonadotropinemia not associated to ovarian failure and induced by factors interfering in radioimmunoassay Fertil Steril. 55 3 637 9 1:STN:280:DyaK3M7mtVOrtw%3D%3D 1900487
23. P Czernichow Van dalem JL G Hennen 1981 Transient neonatal hyperthyrotropinemia: a factitious syndrome due to the presence of heterophilic antibodies in the plasma of infants and their mothers J Clin Endocrinol Metab. 53 2 387 93 10.1210/jcem-53-2-387 1:CAS:528:DyaL3MXltFWhsL0%3D 6894763
24. A Larsson G Hedenborg A Carlstrom 1981 Placental transfer of maternal anti-rabbit IgG causing falsely elevated TSH levels in neonates Acta Paediatr Scand. 70 5 699 703 10.1111/j.1651-2227.1981.tb05771.x 1:STN:280: DyaL387htVSrtg%3D%3D 6976675
25. L Berglund NG Holmberg 1989 Heterophilic antibodies against rabbit serum causing falsely elevated gonadotropin levels Acta Obstet Gynecol Scand. 68 4 377 8 10.3109/00016348909028676 1:STN:280:DyaK3c7ktlOquw%3D%3D 2515728
26. L Chatenoud MF Baudrihaye N Chkoff, et al. 1986 Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3 J Immunol. 137 3 830 8 1:CAS:528:DyaL28XkvFGkt7s%3D 3487589
27. RC McCarthy 1988 Interference in immunoenzymometric assays caused by IgM anti-mouse IgG antibodies Arch Pathol Lab Med. 112 9 901 7 1:STN:280: DyaL1czisFyntA%3D%3D 3046559
28. JE Frodin AK Lefvert H Mellstedt 1992 Clinical significance of HAMA in patients treated with mouse monoclonal antibodies Cell Biophys. 21 1-3 153 65 1:STN:280:DyaK2c7lsFartg%3D%3D 1285327
29. M van der Neut Kolfschoten J Schuurman M Losen, et al. 2007 Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange Science. 317 5844 1554 7 10.1126/science.1144603 17872445 (Pubitemid 47417435)
30. J Ingerslev K Christiansen HB Ravn, et al. 2002 Antibodies to heterologous proteins in hemophilia A patients receiving recombinant factor VIII (Recombinate) Thromb Haemost. 87 4 626 34 1:CAS:528:DC%2BD38Xjt1egtLw%3D 12008945